Core Insights - The company is experiencing a normalization in the utilization of its products, particularly ReCell, as reimbursement clarity improves, which is crucial for driving growth [1][2][3] - The fourth quarter of 2025 showed revenue of $17.6 million, with a full-year revenue of approximately $71.6 million, reflecting an 11% growth over 2024 [3][11] - The company expects full-year revenue for 2026 to be between $80 million and $85 million, indicating a growth of approximately 12% to 19% over 2025 [10][11] Revenue and Financial Performance - The fourth quarter revenue of $17.6 million was consistent with revised expectations, while the full-year revenue of $71.6 million marked a consecutive year of growth despite reimbursement challenges [11][12] - Gross margin for the full year was 82.1%, down from 85.8% in 2024, attributed to product mix and inventory reserves [11][12] - Operating expenses in the fourth quarter were $24.7 million, down 5% year-over-year, primarily due to reduced sales and marketing expenses [13][14] Product Utilization and Strategy - The company is focusing on increasing adoption and repeated use of its products—ReCell, CoHiliX, and PermeDerm—within core burn and trauma centers, which account for roughly 90% of revenue [1][5] - ReCell remains the foundation of the business, supported by clinical evidence demonstrating faster healing and improved outcomes [6][7] - The company is transitioning from a ReCell-only strategy to a multiproduct acute wound care platform, which is expected to enhance revenue per patient opportunities [7] Reimbursement and Market Dynamics - Six of the seven Medicare Administrative Contractors (MACs) have published payment rates for ReCell procedures, alleviating previous reimbursement uncertainties [2][25] - The company is actively engaging with the remaining MAC to ensure reimbursement clarity and is optimistic about future developments [25][26] - The focus on establishing a disciplined operating model and improved visibility into cash use is expected to support execution and growth [4][14] Future Outlook - The company aims to maintain disciplined control of operating costs while supporting revenue growth with a stable cost structure [16][17] - The refinancing of debt through a new credit facility is designed to reduce operational friction and support execution [9][15] - The strategy for 2026 includes a commitment to clear reporting and execution, with a focus on delivering on established milestones [18]

Core Insights - Route1 Inc. provided a year-end review of its operational progress in 2025 and outlined strategic priorities for 2026, focusing on recurring revenue and operational optimization in parking technology [1] Group 1: Operational Progress - In 2025, Route1 concentrated on strengthening its parking technology and services platform [1] - The company deepened relationships with parking operators across North America during the year [1] Group 2: Strategic Priorities - For 2026, Route1 aims to continue its focus on recurring revenue and execution discipline [1] - The application of intelligence to real-world parking operations remains a key strategic priority [1]